Skip to search.
 TSX Down 0.39% TSX Ventures Up 0.28%

Bristol-Myers Squibb Company (BMY)

-NYSE
65.26 Up 0.26(0.40%) Mar 27, 4:01PM EDT
|Pre-Market : 65.70 Up 0.44 (0.67%) 8:36AM EDT
Add to Portfolio
Prev Close:65.00
Open:65.19
Bid:65.26 x 100
Ask:66.21 x 100
1y Target Est:65.90
Beta:0.93
Next Earnings Date:28-Apr-15BMY Earnings announcement
Day's Range:65.00 - 66.11
52wk Range:46.30 - 69.20
Volume:4,964,417
Avg Vol (3m):6,391,410
Market Cap:108.47B
P/E (ttm):54.38
EPS (ttm):1.20
Div & Yield:1.48 (2.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMYUp 0.40%108.47B
AZNUp 0.43%88.51B
PFEUp 1.08%211.63B
RHHBYDown 0.23%N/A

Key Statistics

Forward P/E (1 yr):28.50
P/S (ttm):6.80
Ex-Dividend Date:01-Apr-15

Analysts

Annual EPS Est (Dec-15) :1.72
Quarterly EPS Est (Mar-15) :0.50
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):2.33

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback